Avastin — Class I drug recall D-0870-2016
Terminated recall by Pacifico National, Inc. dba AmEx Pharmacy, reported 2016-06-01, distributed nationwide. Non-Sterility: Product tested positive for bacterial contamination.
| Recall number | D-0870-2016 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pacifico National, Inc. dba AmEx Pharmacy, Melbourne, FL, United States |
| Recall initiated | 2015-01-20 |
| Classified | 2016-05-25 |
| Reported by FDA | 2016-06-01 |
| Terminated | 2017-03-09 |
| Distributed | Nationwide (US) |
| Quantity | 836 syringes |
| Reason classes | microbial contamination, sterility |
| Lot numbers | 150116B, 150119R, 150316H |
| Expiration dates | 2015-04-16, 2015-04-19, 2015-06-14 |
Product
Avastin (Bevacizumab) 1.25 mg/0.05 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St Suite J, Melbourne, FL 32901.
Reason for recall
Non-Sterility: Product tested positive for bacterial contamination.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0870-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.